pharmaphorum

NOVEMBER 13, 2020

Pharma businesses need to ensure that they market themselves accordingly to both B2B and B2C. The good news is Pharma businesses have the opportunity to use a multitude of digital marketing channels to advertise on such as LinkedIn, YouTube, Google and Twitter. How to maximise your digital marketing strategy.

Branding 124

Branding Pharmacy Marketing Compliance 124

BioTech 365

OCTOBER 14, 2020

.–(BUSINESS WIRE)–Innovation Associates, a leading-edge provider of high-volume pharmacy automation and software solutions for retail, hospital, federal healthcare, and mail-order pharmacy markets, today announced that the company will now operate and be known as “iA.”

Pharmacy 52

Pharmacy Branding Marketing 52

Intouch Solutions

JANUARY 6, 2021

Amazon Pharmacy’s debut is worrying many, but its long-terms effect on pharma marketing remains uncertain. Read on to learn more about Amazon’s “master plan,” and whether your brand needs to consider a defensive strategy. The post Amazon Pharmacy: How Will It Affect Pharma? appeared first on Intouch Solutions.

Pharmacy 52

Pharmacy Branding Marketing 52

Pharmaceutical Technology

MARCH 8, 2023

Lilly has claimed that a major obstacle to insulin price reduction has been due to pharmacy benefit manager formularies and contracts with insurance providers, and that list prices for insulin have to remain high for insulin to remain on these formularies.

Insulin 264

Insulin Branding Marketing Pharmacy 264

World of DTC Marketing

OCTOBER 4, 2021

Earlier this year, I was asked by a client to write a position paper on using Facebook for the DTC marketing of an oncology product. From my estimates, most of it failed because pharma companies are afraid of misinformation concerning regulations around DTC marketing. Bob Hoffman. When will Facebook be held accountable?

Branding 224

Branding Marketing Pharmacy Pharma Companies 224

XTalks

SEPTEMBER 21, 2023

The company said it cannot “validate the safety or effectiveness of products claiming to contain tirzepatide that are not our own branded product.” Since compounded drugs are not approved by the FDA, the agency says it does not verify their safety, effectiveness or quality before they are marketed.

Pharmacy 59

Pharmacy FDA Approval Drugs Containment 59

STAT News

DECEMBER 5, 2022

In the fight to command the growing market for telehealth, Thirty Madison is staking out new terrain. Over the last year and a half, the 5-year-old digital health startup has been quietly planning to expand into sleep care with a new brand called River.

Marketing 98

Marketing Allergies Pharmacy Branding 98

Pharmacy Checkers

FEBRUARY 14, 2020

Joe and Teresa Graedon, founders of The People’s Pharmacy , not only have an admirable track record of telling health consumers how it is, but also listening to those in their readership. Many readers complained that it just wasn’t cutting it compared to the brand name version. Just switch back to the brand!”

Branding 62

Branding FDA Approval Pharmacy Bioequivalency 62

Pharmaceutical Technology

FEBRUARY 3, 2023

However, after almost seven years of staving off competitors through patents and litigation, Humira’s market-leading position in the US will be affected as Amgen’s adalimumab biosimilar, Amjevita, started to roll out on January 31, 2023. According to GlobalData estimates, in 2022, the adalimumab biosimilars market was valued at $184.2

Marketing 130

Marketing Sales Pharmacy Branding 130

BioPharma Reporter

NOVEMBER 20, 2023

At last monthâs CPHI Barcelona, Sirio launched its new ready-to-market menopause and eye health softgels in a bid to collaborate with over the counter (OTC) brands and large pharmacy chains looking to advance to market faster.

Pharmacy 52

Pharmacy Branding Marketing Development 52

Drug Channels

APRIL 4, 2023

Time for Drug Channels Institute’s annual update on the gross-to-net bubble —the ever-growing dollar gap between sales at brand-name drugs' list prices and their sales at net prices after rebates and other reductions. We estimate that the gross-to-net bubble reached $223 billion for patent-protected brand-name drugs in 2022.

Marketing 57

Marketing Branding Sales Pharmacy 57

Pharmaceutical Technology

JULY 25, 2022

Despite this, specialty generics are expected to be the domain of a handful of companies with the necessary manufacturing capabilities and legal backing needed for entering the market. As more competitors enter the market, the price of a treatment goes down, explains Stanford University professor of medicine Dr. Kevin Schulman.

Drugs 298

Drugs Manufacturing Production Marketing 298

Drug Channels

JUNE 21, 2023

Time for Drug Channels Institute’s annual update on the gross-to-net bubble —the ever-growing dollar gap between sales at brand-name drugs' list prices and their sales at net prices after rebates and other reductions. We estimate that the gross-to-net bubble reached $223 billion for patent-protected brand-name drugs in 2022.

Marketing 61

Marketing Branding Sales Pharmacy 61

Intouch Solutions

MARCH 2, 2022

My second favorite thing about pharmaceutical marketing is the wonderful customer complexity (the first, of course, is that we can use our marketing superpowers for good not evil). The labyrinth of customers, each with different and often contradictory needs, makes Rx marketing a game of three-dimensional chess.

Marketing 52

Marketing Branding Sales Pharmacy 52

Drug Channels

MARCH 5, 2024

WHAT YOU WILL LEARN In 2023, the Inflation Reduction Act of 2022 (IRA) began to alter the Medicare Part D program and trigger changes in beneficiary out-of-pocket spending, drug prices, pharmacy economics, and market access strategies. Pharmacies and Pharmacy Benefit Managers.

Drugs 84

Drugs Pharmacy Marketing Branding 84

World of DTC Marketing

JUNE 22, 2022

Generic drugs versus branded is also a considerable expense. But Express Scripts, which manages pharmacy benefits for 100 million people, is telling pharmacies to dispense the more expensive Advair brand because it won’t cover Mylan’s generic.

Pharmacy 227

Pharmacy Generic Drugs Life Science Branding 227

pharmaphorum

APRIL 1, 2022

market is just beginning to heat up. Semglee (insulin glargine-yfgn) is the first biosimilar available at the retail pharmacy counter, and it obtained interchangeable status. Innovator products working to maintain market share. In the latter half of 2021, there was lots of exciting movement.

Marketing 59

Marketing Pharmacy FDA Approval Manufacturing 59

XTalks

OCTOBER 10, 2024

While good news for users, the FDA decision sparked a heated response from the compounding pharmacy sector, which has filed a lawsuit against the agency claiming its actions were arbitrary and unlawful. During this time, compounding pharmacies were permitted to produce lower-cost versions of the injectable medications. “The

Pharmacy 52

Pharmacy Drugs Production Branding 52

Drug Channels

AUGUST 13, 2021

Today’s guest post comes from Stacey Little, Senior Vice President of Business Development and Marketing at AssistRx. Stacey discusses how a patient support vendor can help specialty pharmacy patients attain prior authorizations and access critical therapies.

Branding 54

Branding Pharmacy Business Development Manufacturing 54

XTalks

JULY 19, 2024

Compounded GLP-1 medications, created by specialized pharmacies under a special US Food and Drug Administration (FDA) allowance due to ongoing shortage, have become increasingly popular for weight loss. The report also shows a rapid rise in compounding pharmacies.

Pharmacy 85

Pharmacy Drugs Production Sales 85

XTalks

SEPTEMBER 10, 2024

Boruzu, a proteasome inhibitor, offers a more efficient approach to treating multiple myeloma and mantle cell lymphoma by eliminating the reconstitution process required for Velcade, the current branded version of bortezomib. This ready-to-use option significantly cuts down on preparation time, enhancing efficiency for healthcare providers.

FDA Approval 94

FDA Approval Branding Drugs Pharmacy 94

pharmaphorum

FEBRUARY 24, 2021

2021 will be the year when big market access changes – including the far wider use of health economic evaluation – are implemented in Spain. In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes stock of what 2021 could bring for market access in Spain. Higher biosimilar savings.

Marketing 100

Marketing Pharmacy Medicine Branding 100

Drug Channels

MAY 21, 2024

WHAT YOU WILL LEARN The federal 340B Drug Pricing Program continues to grow much more quickly than the overall pharmaceutical market. DCI estimates that 340B discounts equated to more than 17% of total value of gross-to-net reductions for brand-name pharmaceuticals. Pharmacies and Pharmacy Benefit Managers.

Pharmacy 52

Pharmacy Drugs Branding Manufacturing 52

Druggist

MARCH 23, 2021

In recent months, ibuprofen’s price went up significantly, with many shops and pharmacies being out of stock of ‘cheap’ ibuprofen. Firstly, I will discuss the availability of branded ibuprofen. Ibuprofen alternatives – branded ibuprofen 200mg. Other brands of ibuprofen 200mg. Summary: What is ibuprofen?

Drugs 92

Drugs Pharmacy Containment Branding 92

Drug Channels

FEBRUARY 23, 2021

In this issue: Payers confess: Patients lose from copay accumulators Humana joins the Express Scripts GPO Hospitals vs. PBMs over specialty pharmacy white bagging Let’s all follow the Buy-and-Bill Dollar! Plus, entrepreneurial pharmacy owner Dave Marley demonstrates the power of innovation. More to come. Marley Drug generated $1.7

Pharmacy 52

Pharmacy Drugs Production Generic Drugs 52

Pharma Mirror

JANUARY 24, 2023

Neuraxpharm Belgium will be based in Brussels and will distribute and market prescription brand The post Neuraxpharm completes its presence in Benelux appeared first on Pharma Mirror Magazine.

Branding 130

Branding Marketing Pharmacy 130

Drug Channels

OCTOBER 23, 2023

A program driven by market dynamics and led by champions of channel strategy, join now to master the complexities of pharmacy and distribution models to accelerate market access –It's all happening December 11-13, 2023. Why should you attend this pivotal event? How is health policy affecting the distribution channel?

Pharmacy 61

Pharmacy Marketing Production Drugs 61

pharmaphorum

JANUARY 8, 2021

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. With medical staff working tirelessly and lockdown restrictions in place across the world, the way pharma markets medications has changed, too.

Marketing 100

Marketing Doctors Doctor Pharma Companies 100

Pharmaceutical Technology

JUNE 12, 2023

The over-the-counter (OTC) marketing authorisation for the gel as a de novo medical device means the FDA has followed suit after the treatment received CE marking in Europe and UKCA marking in the UK in 2021 and 2022, respectively. The addition of a topical gel to pharmacy shelves expands treatment options available to those with ED.

FDA Approval 130

FDA Approval Pharmacy Marketing Branding 130

Pharma Marketing Network

NOVEMBER 3, 2021

In the last 2 years, and accelerated by Covid, native advertising has exploded across healthcare for DTC and HCP marketing. Native ads have been adopted by all healthcare industries including pharma, device, health systems, retailers, pharmacies, payers, and the gamut of regional service providers.

Branding 105

Branding Marketing Sales Production 105

World of DTC Marketing

OCTOBER 25, 2021

In addition to immediate access to a physician, they offer on-site labs to analyze blood, MRI and CAT scan machines, pharmacies, and a full range of OTC products. In my opinion, these total urgent care centers will be springing up throughout the US and could even be branded under retailers like Wal*Mart or Target.

Containment 257

Containment Branding Pharmacy Production 257

pharmaphorum

FEBRUARY 1, 2021

Italy was working up big changes in market access throughout 2020 which will be implemented in 2021. In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes stock of what 2021 could bring for market access in Italy. The post 2021 market access prospects for Italy appeared first on.

Marketing 52

Marketing Medicine Pharmacy Gene Therapy 52

World of DTC Marketing

JULY 27, 2022

A drug’s out-of-pocket cost is primarily the result of decisions made by insurance companies and pharmacy benefit managers (PBMs). In 2021 pharma provided a staggering $204 billion in price concessions for brand-name medicines to PBMs. The problem is that PBMs are out for themselves and shareholders, not patients.

Pharmacy 226

Pharmacy Generic Drugs Medicine Drugs 226

Pharmaceutical Technology

MARCH 24, 2023

Amgen’s (US) Amjevita (adalimumab) is the first Humira biosimilar, launched in February 2023, and seven other FDA-approved biosimilars are expected to arrive on the US market later this year. AbbVie had reached settlement agreements with the biosimilar manufacturers to keep the biosimilars off the US market until 2023.

FDA Approval 147

FDA Approval Marketing Manufacturing Sales 147

pharmaphorum

JUNE 6, 2022

American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC), a public-benefit corporation and online pharmacy that provides patients access to medications at a lower cost. . We want to work with every source of medications, branded or generic.”

Drugs 144

Drugs Manufacturing Pharmacy Branding 144

XTalks

MAY 17, 2024

The settlement requires Totality to take several specific corrective actions, which include refraining from making any statements that suggest the spa’s products are genuine, FDA-approved Lilly products, and stopping the use of Eli Lilly branding in promoting any of the products.

Sales 52

Sales FDA Approval Pharmacy Production 52

World of DTC Marketing

AUGUST 7, 2022

What you pay depends on your drug plan, whether your medication is subject to a deductible, the price tier or level it’s assigned by your plan, how much you have already spent on drugs during a given year, where you buy them, and — in the case of brand-name drugs — the whims of the pharma, PBM and insurance companies.

Doctors 263

Doctors Doctor Generic Drugs Drugs 263